# RAMELTEON
> **ANDA216209** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2022-11-25
## Drug
- **FDA Application Number:** ANDA216209
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RAMELTEON
- **Generic name:** RAMELTEON
- **Active ingredients:** RAMELTEON
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** Xiromed, LLC
- **First approval:** 2022-11-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216209)
---
*AI Analytics · CC0 1.0*